Anthera Pharmaceuticals Inc:企業のM&A・事業提携・投資動向

◆英語タイトル:Anthera Pharmaceuticals Inc - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report
◆商品コード:DATA904C1967
◆発行会社(調査会社):MarketLine
◆発行日:2018年7月
◆ページ数:82
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD350 ⇒換算¥51,800見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD700 ⇒換算¥103,600見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD1,050 ⇒換算¥155,400見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はMarketLine社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
MarketLine社の概要はこちらでご確認いただけます。



【レポートの概要】

Anthera Pharmaceuticals Inc – Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report
Summary

Marketline’s Anthera Pharmaceuticals Inc Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestments, capital raisings, venture capital investments, ownership and partnership transactions undertaken by Anthera Pharmaceuticals Inc since January2007.

Synopsis

Marketline’s Company Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage.

Key Highlights

This report includes Anthera Pharmaceuticals Inc’s contact information and business summary, tables, graphs, a list of partners and targets, a breakdown of financial and legal advisors, deal types, top deals by deal value, detailed deal reports, and descriptions and contact details of the partner, target, investor, and vendor firms, where disclosed.

The profile also includes detailed deal reports for all M&A, private equity, public offering, venture financing, partnership and divestment transactions undertaken by Anthera Pharmaceuticals Inc. These deal reports contain information about target company financials, sources of financing, method of payment, deal values, and advisors for various parties, where disclosed.

Scope

- Provides intelligence on Anthera Pharmaceuticals Inc’s M&A, strategic partnerships and alliances, capital raising and private equity transactions.
- Detailed reports of various financial transactions undertaken by Anthera Pharmaceuticals Inc and its subsidiaries since 2007.
- Information about key financial and legal advisors for Anthera Pharmaceuticals Inc’s financial deals transactions.
- Financial deals tables and charts covering deal value and volumes trend, deal types and geography-based deal activity.

Reasons to buy

- Access comprehensive financial deals data along with charts and graph covering M&A, private equity, and partnerships and alliances.
- Form an independent opinion about Anthera Pharmaceuticals Inc’s growth strategies through the organic and inorganic activities undertaken since 2007.
- Track your competitors’ business structure and growth strategies.

【レポートの目次】

Table of Contents
COMPANY OVERVIEW AND KEY FACTS 2
TABLE OF CONTENTS 5
LIST OF TABLES 6
LIST OF FIGURES 6
TARGETS AND PARTNERS 7
MERGERS & ACQUISITIONS 8
Mergers and Acquisitions – Overview 8
Mergers and Acquisitions – Deal reports 9
PARTNERSHIP 12
Partnership – Overview 12
Partnership – Deal reports 13
CAPITAL RAISING 32
Capital Raising – Overview 32
Capital Raising – Deal reports 33
APPENDIX 72
Contact Us 72
About MarketLine Financial Deals Database 72
Deal Definition and Methodology 74
About MarketLine 81

List of Tables
Table 1: Anthera Pharmaceuticals M&A volume and value trend (2014-YTD2018)
Table 2: Anthera Pharmaceuticals M&A activity by geography (2014-YTD2018)
Table 3: Anthera Pharmaceuticals partnership volume and value trend (2014-YTD2018)
Table 4: Anthera Pharmaceuticals partnership trend by key deal type (2014-YTD2018)
Table 5: Anthera Pharmaceuticals capital raising volume and value trend (2014-YTD2018)
Table 6: Anthera Pharmaceuticals capital raising by deal type (2014-YTD2018)

List of Figures
Figure 1: Anthera Pharmaceuticals M&A volume and value trend (2014-YTD2018)
Figure 2: Anthera Pharmaceuticals M&A activity by geography (2014-YTD2018)
Figure 3: Anthera Pharmaceuticals partnership volume and value trend (2014-YTD2018)
Figure 4: Anthera Pharmaceuticals partnership trend by key deal type (2014-YTD2018)
Figure 5: Anthera Pharmaceuticals capital raising volume and value trend (2014-YTD2018)
Figure 6: Anthera Pharmaceuticals capital raising by deal type (2014-YTD2018)

★海外企業調査レポート[Anthera Pharmaceuticals Inc:企業のM&A・事業提携・投資動向]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Sky plc (SKY):企業の財務・戦略的SWOT分析
    Sky plc (SKY) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the pot …
  • Jackson Electric Membership Corp:企業の戦略的SWOT分析
    Jackson Electric Membership Corp - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major pr …
  • 3i Infotech Ltd (3IINFOTECH):企業の財務・戦略的SWOT分析
    3i Infotech Ltd (3IINFOTECH) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknes …
  • DCC Plc (DCC):石油・ガス:M&Aディール及び事業提携情報
    Summary DCC Plc (DCC) is a diversified company that offers international sales, marketing, distribution and business support services. The company operates through its business divisions such as LPG, retail, and oil, healthcare and technology. Its LPG business markets liquefied petroleum gas and nat …
  • Royal Energy Resources Inc (ROYE):石油・ガス:M&Aディール及び事業提携情報
    Summary Royal Energy Resources Inc (Royal Energy), formerly World Marketing Inc is an oil and gas company that invest on energy industry and its properties. The company acquires, operates and develops coal, natural gas, and renewable fuels energy assets. It offers services such as energy recovery an …
  • STRABAG International GmbH:企業の戦略的SWOT分析
    STRABAG International GmbH - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products …
  • Essar Oil Ltd-石油・ガス分野:企業M&A・提携分析
    Summary Essar Oil Limited (Essar Oil) is an integrated oil and gas company. The company acquires, explores, develops, and produces oil and gas from its assets. It refines crude oil to produce LPG, naphtha, light diesel oil, Aviation Turbine Fuel (ATF) and kerosene. The company markets its petroleum …
  • Inform Diagnostics Inc:医療機器:M&Aディール及び事業提携情報
    Summary Inform Diagnostics Inc(Inform Diagnostics) formerly known as Miraca Life Sciences, a subsidiary of Miraca Holdings Inc, is an anatomic pathology laboratory that offers diagnostic services. The laboratory provides services in the areas of breast health, dermatology, gastroenterology, hematolo …
  • KONE Corporation:企業のM&A・事業提携・投資動向
    KONE Corporation - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's KONE Corporation Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), dives …
  • Cytodyn Inc (CYDY):製薬・医療:M&Aディール及び事業提携情報
    Summary Cytodyn Inc (Cytodyn) is a clinical-stage biotechnology company focused on the clinical development and potential commercialization of humanized monoclonal antibodies t for the treatment of Human Immunodeficiency Virus (HIV) infections. The company's products pipeline include PRO 140, Cytofe …
  • Hokkaido Electric Power Co Inc (9509):企業の財務・戦略的SWOT分析
    Hokkaido Electric Power Co Inc (9509) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths an …
  • TTCL Public Company Limited (TTCL):電力:M&Aディール及び事業提携情報
    Summary TTCL Public Company Limited (TTCL), a subsidiary of Italian-Thai Development Public Company Limited, is a provider of engineering and construction services. The company offers integrated engineering, procurement and construction (EPC) services, feasibility study and project management servic …
  • LivaNova PLC (LIVN):企業の製品パイプライン分析2018
    Summary LivaNova PLC (LivaNova) is a medical technology company that offers medical devices for cardiac surgery and neuromodulation. The company’s neuromodulation provides vagus nerve stimulation therapy system, an implantable device for the people affected by treatment-resistant epilepsy, depressio …
  • Kellstrom Defense Aerospace, Inc.:企業の戦略・SWOT・財務情報
    Kellstrom Defense Aerospace, Inc. - Strategy, SWOT and Corporate Finance Report Summary Kellstrom Defense Aerospace, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, pro …
  • SK Telecom Co., Ltd.:企業の戦略・SWOT・財務分析
    SK Telecom Co., Ltd. - Strategy, SWOT and Corporate Finance Report Summary SK Telecom Co., Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings …
  • VTB Bank:企業のM&A・事業提携・投資動向
    VTB Bank - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's VTB Bank Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestments, capital …
  • Taiwan High Speed Rail Corporation:企業の戦略・SWOT・財務情報
    Taiwan High Speed Rail Corporation - Strategy, SWOT and Corporate Finance Report Summary Taiwan High Speed Rail Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, p …
  • Newfoundland and Labrador Hydro:企業の戦略的SWOT分析
    Newfoundland and Labrador Hydro - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major pro …
  • Indeck Energy Services Inc:企業の戦略的SWOT分析
    Indeck Energy Services Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products …
  • Epigenomics AG (ECX):医療機器:M&Aディール及び事業提携情報
    Summary Epigenomics AG (Epigenomics) is a molecular diagnostics company which develops and commercializes in-vitro diagnostic (IVD) tests for screening, early detection and diagnosis of cancer. Its lead product, Epi proColon is a blood-based test for rapid detection of colorectal cancer; and Epi pro …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆